Eli Lillys Zepbound set to eclipse Wegovy in U.S. obesity drug market Eli Lillys new obesity drug poised to challenge ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

SYDNEY, Jan 2 (Reuters) - Australia's home prices marked the first monthly decline in almost two years in December as high mortgage rates stretched affordability and more sellers emerged after a ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Following positive results from its SURMOUNT-5 trial, Eli Lilly’s Zepbound (tirzepatide) will surpass Novo Nordisk’s Weogvy (semaglutide) in the obesity treatment market, according to a ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

Andrew Morse still remembers the moment he learnt a terrible secret about his adopted father Ron that also haunts one of Australia's most prestigious private schools. Marisha Smith, 19 ...

Virat Kohli's form 8h 3 things India need to do right to beat Australia in the 5th BGT 2024-25 Test ft. Rishabh Pant 3 things India need to do right to beat Australia in the 5th BGT 2024-25 Test ft.

Sleep apnea causes people to stop and start breathing repeatedly Zepbound is first drug approved by FDA to help treat it Two studies found that those who used it saw reduction in apnea events ...

Here’s how it works. Happy New Year! With the changing of calendars comes new content for the best streaming services in Australia. The platforms are welcoming some hot new additions to their ...